Atrx promotes heterochromatin formation at retrotransposons is a research paper published in EMBO reports (2015). On theSindex it has a DataRank of 4.8. It has been cited 183 times, with 153 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.782
From this paper's citation signal
Citation Network Contribution
4.0
From 125 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 153 citers.
Deutsche Forschungsgemeinschaft
Grant: SFB 1064
Deutsche Forschungsgemeinschaft
Grant: SPP1356
MeSH Terms
Keywords
Additional file 10 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 10 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 11 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 11 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 12 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 12 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 1 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 1 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 2 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 2 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 3 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 3 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 4 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 4 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 5 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 5 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 6 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 6 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 7 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
Additional file 7 of Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia